Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 21,697 results that match your search.21,697 results
  • Entitlement disputes under the UK Patents Act have recently undergone something of a revival with several cases reaching the courts. Interestingly though, Patent Office figures reveal that the number of entitlement disputes filed before the Patent Office has remained steady over recent years as has the number of cases referred from the Patent Office to the UK courts. Why then is everyone discussing entitlement disputes under UK law?
  • Graeme Hall and John Glengarry of Buddle Findlay assess the IP enforcement options available in New Zealand and identify a trend towards alternative forms of dispute resolution
  • In an extract from their book Little Blues: How to Build a Culture of Intellectual Property Within a Small Technology Company, André Carter and Raymond Millien examine how a small business with IP rights can also nurture an IP culture
  • Ian Finch and David Marriott of James & Wells laud New Zealand's virtues as a test market for IP litigation cases, or to test the strength of patents and trade marks
  • The US patent law is about to undergo a major change with a raft of reforms set to be implemented. These changes are considered to be the most comprehensive since Congress passed the 1952 patent Act. But, the path has not been smooth, with voices of dissent materializing as the government carves out its plans. MIP and Oblon, Spivak, McClelland, Maier & Neustadt jointly hosted a roundtable discussion – at a real roundtable – in Washington DC in late summer, to discuss some of those concerns and what really needs to be done
  • In the latest twist in the long-running battle between Sanofi-aventis and Bristol-Myers Squibb and Apotex, the originator drugs companies secured a preliminary injunction against the Canadian company to stop it selling generic versions of their blockbuster anti-blood clotting drug Plavix.
  • Do you know a DNS from a DIG? What's the difference between a domainer and a typosquatter? If you want to protect your brands on the internet, then you need to know the answers to questions such as these. Nick Wood and Michael Murphy provide an A to Z guide to domain name jargon
  • Emma Barraclough, London
  • New rules on electronic discovery are about to come into force for all federal courts in the US. Steven M Gruskin and Carl J Pellegrini of Sughrue Mion, PLLC explain how they will affect potential litigants